A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 39, 2008, Pages 15070-15075

  Sibley, Christopher D ^a   Parkins, Michael D ^a,b   Rabin, Harvey R ^a,b   Duan, Kangmin ^a,c   Norgaard, Jens C ^a   Surette, Michael G ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c NORTHWEST UNIVERSITY   (China)

Author keywords

Microbial communities; Normal microbiota; Oropharyngeal flora; Streptococcus milleri

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; CYSTIC FIBROSIS; DISEASE EXACERBATION; LUNG INFECTION; MICROBIAL COMMUNITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS MILLERI; ADULT; BACTERIAL INFECTION; DRUG EFFECT; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; LUNG; MALE; MICROBIOLOGY; MIDDLE AGED; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPUTUM; STREPTOCOCCUS CONSTELLATUS;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS MILLERI;

ADULT; BACTERIAL INFECTIONS; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUNG; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PSEUDOMONAS AERUGINOSA; SPUTUM; STREPTOCOCCUS CONSTELLATUS;

EID: 54449089545     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0804326105     Document Type: Article

References (59)

1. Lyczak JB, Cannon CL, Pier GB (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15:194-222.
2. Matsui H, et al. (1998) Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95:1005-1015.
3. Goldman MJ, et al. (1997) Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553-560.
4. Smith JJ, Travis SM, Greenberg EP, Welsh MJ (1996) Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229-236.
5. Ong EL, et al. (1989) Infective respiratory exacerbations in young adults with cystic fibrosis: Role of viruses and atypical microorganisms. Thorax 44:739-742.
6. Hordvik NL, et al. (1989) Effects of acute viral respiratory tract infections in patients with cystic fibrosis. Pediatr Pulmonol 7:217-222.
7. Gilligan PH, Kiska DL, Appleman MD (2006) Cumitech: Cystic fibrosis microbiology, ed Appleman MD (Am Soc Microbiol, Washington, D.C.), Vol 43.
8. Rajan S, Saiman L (2002) Pulmonary infections in patients with cystic fibrosis. Semin Respir Infect 17:47-56.
9. Sibley CD, Rabin H, Surette MG (2006) Cystic fibrosis: A polymicrobial infectious disease. Future Microbiology 1:53-61.
10. Rogers GB, et al. (2003) Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 41:3548-3558.
11. Rogers GB, et al. (2004) characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 42:5176-5183.
12. Rogers GB, et al. (2006) Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. J Clin Microbiol 44:2601-2604.
13. Duan K, Dammel C, Stein J, Rabin H, Surette MG (2003) Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol 50:1477-1491.
14. Tunney MM, et al. (2008) Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 177:995-1001.
15. Harris JK, et al. (2007) Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci USA 104:20529-20533.
16. Whiley RA, Fraser H, Hardie JM, Beighton D (1990) Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the "Streptococcus milleri group." J Clin Microbiol 28:1497-1501.
17. Whiley RA, Beighton D, Winstanley TG, Fraser HY, Hardie JM (1992) Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): Association with different body sites and clinical infections. J Clin Microbiol 30:243-244.
18. Ball LC, Parker MT (1979) The cultural and biochemical characters of Streptococcus milleri strains isolated from human sources. J Hyg (Lond) 82:63-78.
19. Poole PM, Wilson G (1979) Occurrence and cultural features of Streptococcus milleri in various body sites. J Clin Pathol 32:764-768.
20. Ruoff KL (1988) Streptococcus anginosus ("Streptococcus milleri"): The unrecognized pathogen. Clin Microbiol Rev 1:102-108.
21. Edmiston CE, Jr, et al. (1991) Streptococcus milleri group (Streptococcus anginosus): Recovery from intra-abdominal and soft tissue sites. Ann Clin Lab Sci 21:56-61.
22. Parker MT, Ball LC (1976) Streptococci and aerococci associated with systemic infection in man. J Med Microbiol 9:275-302.
23. Porta G, et al. (1998) Thoracic infection caused by Streptococcus milleri. Eur Respir J 12:357-362.
24. Belko J, Goldmann DA, Macone A, Zaidi AK (2002) Clinically significant infections with organisms of the Streptococcus milleri group. Pediatr Infect Dis J 21:715-723.
25. Chua D, Reinhart HH, Sobel JD (1989) Liver abscess caused by Streptococcus milleri. Rev Infect Dis 11:197-202.
26. Gossling J (1988) Occurrence and pathogenicity of the Streptococcus milleri group. Rev Infect Dis 10:257-285.
27. Hardwick RH, Taylor A, Thompson MH, Jones E, Roe AM (2000) Association between Streptococcus milleri and abscess formation after appendicitis. Ann R Coll Surg Engl 82:24-26.
28. Mirick GS, Thomas I, Curen EC, Horsfall FL (1944) Studies of non-haemolytic streptococcus isolated from the respiratory tract of human beings. J Exp Med 80:391-440.
29. Shinzato T, Saito A (1995) The Streptococcus milleri group as a cause of pulmonary infections. Clin Infect Dis 21 Suppl 3:S238-S243.
30. Velghe A, Van den NN, Janssens W, Smeets P, Vogelaers D (2004) Streptococcus milleri-sepsis with lung and brain abscesses. Acta Clin Belg 59:369-372.
31. Molina JM, et al. (1991) Clinical and bacterial features of infections caused by Streptococcus milleri. Scand J Infect Dis 23:659-666.
32. Van der AP (1985) Clinical significance of Streptococcus milleri. Eur J Clin Microbiol 4:386-390.
33. Jacobs JA, Pietersen HG, Stobberingh EE, Soeters PB (1994) Bacteremia involving the "Streptococcus milleri" group: Analysis of 19 cases. Clin Infect Dis 19:704-713.
34. Murray HW, Gross KC, Masur H, Roberts RB (1978) Serious infections caused by Streptococcus milleri. Am J Med 64:759-764.
35. Salavert M, et al. (1996) Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci. Eur J Clin Microbiol Infect Dis 15:365-371.
36. Clarridge JE, III, Osting C, Jalali M, Osborne J, Waddington M (1999) Genotypic and phenotypic characterization of "Streptococcus milleri" group isolates from a Veterans Administration hospital population. J Clin Microbiol 37:3681-3687.
37. Yamamoto N, et al. (2002) Trends in antimicrobial susceptibility of the Streptococcus milleri group. J Infect Chemother 8:134-137.
38. Maskell NA, et al. (2005) U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 352:865-874.
39. Hartmann M, Widmer F (2008) Reliability for detecting composition and changes of microbial communities by T-RFLP genetic profiling. FEMS Microbiol Ecol 63:249-260.
40. Magurran AE (1988) in Ecological Diversity and Its Measurements (Princeton Univ Press, Princeton), p 179.
41. Parkins MD, Sibley CD, Surette MG, Rabin HR (2008) The Streptococcus milleri group - An unrecognized cause of disease in cystic fibrosis: A case series and literature review. Pediatr Pulmonol 43(5):490-497.
42. Cade A, Denton M, Brownlee KG, Todd N, Conway SP (1999) Acute bronchopulmonary infection due to Streptococcus milleri in a child with cystic fibrosis. Arch Dis Child 80:278-279.
43. Ball JL, Malhotra RM, Leong P, Bacon AS (2000) The importance of recognizing Streptococcus milleri as a cause of orbital cellulites. Eye 14(5):814-815.
44. Bourgault AM, Wilson WR, Washington JA (1979) Antimicrobial susceptibilities of species of viridans streptococci. J Infect Dis 140:316-321.
45. Jacobs JA, Stobberingh EE (1995) Hydrolytic enzymes of Streptococcus anginosus, Streptococcus constellatus, and Streptococcus intermedius in relation to infection. Eur J Clin Microbiol Infect Dis 14:818-820.
46. Shain H, Homer KA, Beighton D (1996) Degradation and utilization of chondroitin sulphate by Streptococcus intermedius. J Med Microbiol 44:372-380.
47. Unsworth PF (1989) Hyaluronidase production in Streptococcus milleri in relation to infection. J Clin Pathol 42:506-510.
48. 2-dependent streptococci. J Clin Microbiol 12:27-31.
49. Marshall R, Kaufman AK (1981) Production of deoxyribonuclease, ribonuclease, coagulase, and hemolysins by anaerobic gram-positive cocci. J Clin Microbiol 13:787-788.
50. Steffen EK, Hentges DJ (1981) Hydrolytic enzymes of anaerobic bacteria isolated from human infections. J Clin Microbiol 14:153-156.
51. Piscitelli SC, Shwed J, Schreckenberger P, Danziger LH (1992) Streptococcus milleri group: Renewed interest in an elusive pathogen. Eur J Clin Microbiol Infect Dis 11:491-498.
52. Han JK, Kerschner JE (2001) Streptococcus milleri: An organism for head and neck infections and abscess. Arch Otolaryngol Head Neck Surg 127:650-654.
53. Smith EE, et al. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 103:8487-8492.
54. Liu WT, Marsh TL, Cheng H, Forney LJ (1997) Characterization of microbial diversity by determining terminal restriction fragment length polymorphisms of genes encoding 16S rRNA. Appl Environ Microbiol 63:4516-4522.
55. National Committee for Clinical Laboratory Standards (2000) Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically. (NCCLS, Wayne, PA).
56. Bartie KL, Wilson MJ, Williams DW, Lewis MA (2000) Macrorestriction fingerprinting of "Streptococcus milleri" group bacteria by pulsed-field gel electrophoresis. J Clin Microbiol 38:2141-2149.
57. Rogers GB, et al. (2005) Bacterial activity in cystic fibrosis lung infections. Respir Res 6:49.
58. Kent AD, Smith DJ, Benson BJ, Triplett EW (2003) Web-based phylogenetic assignment tool for analysis of terminal restriction fragment length polymorphism profiles of microbial communities. Appl Environ Microbiol 69:6768-6776.
59. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.